Daily Market Overview S P 500 And Nasdaq Edge Higher Dow Posts Modest Dip 20260408 1 Is Cognex Cgnx Stock Declining Price At 48.94 Down 0.47 20260406 Is Dine Brands Din Stock Stronger Than Peers Price At 27.59 Up 8.20 20260406 BP Ousts Chairman Albert Manifold Over Serious Conduct Concerns Shares Decline Geopolitical Jitters Deepen as Putins Nuclear Doctrine Update Spurs Selloff in US Stocks and Bonds Pet Supplies Retailer Files Chapter 11 Bankruptcy Amid Industry Challenges Consumer Sentiment Sinks to Historic Low in May as Gas Prices Surge Amid Iran Conflict Vickers Top Insider Picks Report for May 28 2026 Highlights Key Transactions UK Energy Policy Under Scrutiny Ministerial MiniMeasures May Not Address Structural Vulnerabilities GXAI Q1 2026 Earnings EPS Misses Estimates by 1765 Stock Declines OBK Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Evolv Technologies Q1 2026 Earnings Narrowing Loss Beats Expectations Stock Rises FROG Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction GeneDx Holdings Corp WGS Q1 2026 Earnings Deep EPS Miss Overshadows Progress Braze Inc Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction American Drive Acquisition Co ADAC Holds Steady Near 994 as SPAC Investors Eye Key Levels ProFrac Holding Corp ACDC Edges Higher as Shares Hold Above Key Support Sonos SONO Rallies 348 as Shares Approach Key Resistance Hanover Insurance Group THG Retreats 2 as Insurance Sector Faces Renewed Pressure ImmuCell Corporation ICCC Surges 375 to 1050 as Bulls Test Key Resistance MOLN Shares Dip 311 as Biotech Stock Tests Support Near 385 Context Therapeutics Inc CNTX Shows Modest Gains Near Key Resistance Level WESCO International WCC Gains Momentum Breaking Above Key Support Levels Northwest Bancshares NWBI Holds Steady at 1397 as Traders Eye Key Support and Resistance Roman DBDR Acquisition Corp II Unit DRDBU Holds Steady at 1052 as Support Levels Are Tested American Airlines Reports Resilient Travel Demand Offsets Rising Fuel Costs Houlihan Lokey Q1 2026 Earnings Earnings Miss Weighs on Shares as Advisory Volumes Remain Subdued Acrivon Therapeutics ACRV Edges Higher Biotech Stock Tests Key Resistance at 177